MedTrace Logo

Anabolic Steroid and Propranolol in Paediatric Burn

NCT05805553 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2023-04-10

No results posted yet for this study

Summary

propranolol and anabolic steroids have a role in pediatric burn patients and their combined effects are to be studied here. They decrease the catabolic response to burn trauma and minimize the duration of growth arrest hence improving the outcome

Conditions

  • Arrest
  • Bone
  • Development
  • Growth

Interventions

DRUG

Propranolol

2mg/kg/day in 3-4 dividd doses

DRUG

Nandrolone Decanoate

1mg/kg weekly

Sponsors & Collaborators

  • King Edward Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2023-09-28
Completion
2023-09-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05805553 on ClinicalTrials.gov